Data from the UALCAN database indicated that CCT4, CCT5, CCT6A, and CCT8 exhibited significantly higher promoter methylation in normal tissues than in tumor tissues (Fig. 3C), suggesting that low promoter methylation may be responsible for upregulating these CCTs in LUAD. The gene discussed is CCT6A; the disease is neoplasm.